These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33416917)

  • 1. High-dose midodrine is not effective for treatment of persistent hypotension in the intensive care unit.
    Santer P; Eikermann M
    Intensive Care Med; 2021 Feb; 47(2):252-253. PubMed ID: 33416917
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylene blue, midodrine, and pseudoephedrine: a review of alternative agents for refractory hypotension in the intensive care unit.
    Van Berkel MA; Fuller LA; Alexandrov AW; Jones GM
    Crit Care Nurs Q; 2015; 38(4):345-58. PubMed ID: 26335214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions.
    Levine AR; Meyer MJ; Bittner EA; Berg S; Kalman R; Stanislaus AB; Ryan C; Ball SA; Eikermann M
    J Crit Care; 2013 Oct; 28(5):756-62. PubMed ID: 23845791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial).
    Anstey MH; Wibrow B; Thevathasan T; Roberts B; Chhangani K; Ng PY; Levine A; DiBiasio A; Sarge T; Eikermann M
    BMC Anesthesiol; 2017 Mar; 17(1):47. PubMed ID: 28327122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral midodrine is effective for the treatment of hypotension associated with carotid artery stenting.
    Sharma S; Lardizabal JA; Bhambi B
    J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):94-7. PubMed ID: 18495904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial.
    Santer P; Anstey MH; Patrocínio MD; Wibrow B; Teja B; Shay D; Shaefi S; Parsons CS; Houle TT; Eikermann M;
    Intensive Care Med; 2020 Oct; 46(10):1884-1893. PubMed ID: 32885276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midodrine administration during critical illness: fixed-dose or titrate to response?
    Riker RR; Gagnon DJ
    Intensive Care Med; 2021 Feb; 47(2):249-251. PubMed ID: 33237345
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of midodrine in the treatment of dialysis-associated hypotension.
    Perazella MA
    Expert Opin Drug Saf; 2003 Jan; 2(1):37-47. PubMed ID: 12904123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot, feasibility, randomised controlled trial of midodrine as adjunctive vasopressor for low-dose vasopressor-dependent hypotension in intensive care patients: The MAVERIC study.
    Costa-Pinto R; Yong ZT; Yanase F; Young C; Brown A; Udy A; Young PJ; Eastwood G; Bellomo R
    J Crit Care; 2022 Feb; 67():166-171. PubMed ID: 34801917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of midodrine (Gutron) to treat permanent hypotension in a chronic hemodialysis patient.
    Montagnac R; Clavel P; Delhotal-Landes B; Flouvat B; Poulain S; Schllinger F
    Clin Nephrol; 2001 Aug; 56(2):162-8. PubMed ID: 11522094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock.
    Tchen S; Sullivan JB
    J Crit Care; 2020 Jun; 57():148-156. PubMed ID: 32145658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Midodrine for Hypotension Outside of the Intensive Care Unit.
    Gutman LB; Wilson BJ
    J Popul Ther Clin Pharmacol; 2017 Aug; 24(3):e45-e50. PubMed ID: 28873293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of sequential dialysis, mannitol and midodrine in managing children prone to dialysis failure.
    Hothi DK; Harvey E; Goia CM; Geary D
    Pediatr Nephrol; 2009 Aug; 24(8):1587-91. PubMed ID: 19294425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuation of Newly Initiated Midodrine Therapy After Intensive Care and Hospital Discharge: A Single-Center Retrospective Study.
    Rizvi MS; Nei AM; Gajic O; Mara KC; Barreto EF
    Crit Care Med; 2019 Aug; 47(8):e648-e653. PubMed ID: 31107279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of midodrine hydrochloride on blood pressure and cerebral blood flow during orthostasis in persons with chronic tetraplegia.
    Wecht JM; Rosado-Rivera D; Handrakis JP; Radulovic M; Bauman WA
    Arch Phys Med Rehabil; 2010 Sep; 91(9):1429-35. PubMed ID: 20801263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midodrine for the treatment of intradialytic hypotension.
    Lim PS; Yang CC; Li HP; Lim YT; Yeh CH
    Nephron; 1997; 77(3):279-83. PubMed ID: 9375820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Use of Midodrine in the ICU: A Single-Center Retrospective Case Series.
    Rizvi MS; Trivedi V; Nasim F; Lin E; Kashyap R; Andrijasevic N; Gajic O
    Crit Care Med; 2018 Jul; 46(7):e628-e633. PubMed ID: 29613861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of midodrine on exercise-induced hypotension and blood pressure recovery in autonomic failure.
    Schrage WG; Eisenach JH; Dinenno FA; Roberts SK; Johnson CP; Sandroni P; Low PA; Joyner MJ
    J Appl Physiol (1985); 2004 Nov; 97(5):1978-84. PubMed ID: 15273244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midodrine in intradialytic hypotension.
    Izhar M
    Int J Artif Organs; 1999 Aug; 22(8):529-30. PubMed ID: 10533907
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter to the Editor: "Midodrine to liberate ICU patients from intravenous vasopressors: Another negative fixed-dose trial".
    Riker RR; Gagnon DJ
    J Crit Care; 2022 Jun; 69():153995. PubMed ID: 35152142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.